Clinical Study of Endostatin in Improving Radiation Pneumonia and Fibrosis
Status:
Unknown status
Trial end date:
2020-07-31
Target enrollment:
Participant gender:
Summary
To verify the efficacy and safety of endostatin in the treatment of SRILI（symptomatic
radiation-induced lung injury） and fibrosis. The results of this study are expected to be a
new clinical strategy for the treatment of radiation pneumonia and fibrosis.